Cargando…

Multidrug-resistant Tuberculosis in Central Asia

Multidrug-resistant tuberculosis (MDR-TB) has emerged as a major threat to TB control, particularly in the former Soviet Union. To determine levels of drug resistance within a directly observed treatment strategy (DOTS) program supported by Médecins Sans Frontières in two regions in Uzbekistan and T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cox, Helen Suzanne, Orozco, Juan Daniel, Male, Roy, Ruesch-Gerdes, Sabine, Falzon, Dennis, Small, Ian, Doshetov, Darebay, Kebede, Yared, Aziz, Mohammed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323206/ https://www.ncbi.nlm.nih.gov/pubmed/15200821 http://dx.doi.org/10.3201/eid1005.030718

Ejemplares similares

The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia
por: Cox, Helen Suzanne, et al.
Publicado: (2005)

Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance
por: Cox, Helen, et al.
Publicado: (2006)

Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB among Treatment Failures
por: Cox, Helen S., et al.
Publicado: (2007)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
por: Eker, Barbara, et al.
Publicado: (2008)

Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia
por: Merker, Matthias, et al.
Publicado: (2018)

Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013)

Multidrug-Resistant Tuberculosis, Somalia, 2010–2011
por: Sindani, Ireneaus, et al.
Publicado: (2013)

Performance of MTBDRplus assay in detecting multidrug resistant tuberculosis at hospital level
por: Kebede, Abebaw, et al.
Publicado: (2017)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Whole Genome Sequencing Reveals Complex Evolution Patterns of Multidrug-Resistant Mycobacterium tuberculosis Beijing Strains in Patients
por: Merker, Matthias, et al.
Publicado: (2013)

A Systematic Review of Reported Cost for Smear and Culture Tests during Multidrug-Resistant Tuberculosis Treatment
por: Lu, Chunling, et al.
Publicado: (2013)

Multidrug-resistant tuberculosis around the world: what progress has been made?
por: Falzon, Dennis, et al.
Publicado: (2015)

Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan
por: Trauer, James M., et al.
Publicado: (2016)

High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
por: Sanchez-Padilla, Elisabeth, et al.
Publicado: (2012)

The experience of scaling up a decentralized, ambulatory model of care for management of multidrug-resistant tuberculosis in two regions of Ethiopia
por: Molla, Yohannes, et al.
Publicado: (2017)

External Quality Assessment for Tuberculosis Diagnosis and Drug Resistance in the European Union: A Five Year Multicentre Implementation Study
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2016)

The need to accelerate access to new drugs for multidrug-resistant tuberculosis
por: Cox, Helen S, et al.
Publicado: (2015)

Double infection with a resistant and a multidrug-resistant strain of Mycobacterium tuberculosis.
por: Niemann, S, et al.
Publicado: (2000)

Molecular detection of multidrug-resistant tuberculosis among smear-positive pulmonary tuberculosis patients in Jigjiga town, Ethiopia
por: Brhane, Mussie, et al.
Publicado: (2017)

Safety and availability of clofazimine in the treatment of multidrug and extensively drug-resistant tuberculosis: analysis of published guidance and meta-analysis of cohort studies
por: Hwang, Thomas J, et al.
Publicado: (2014)

Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method
por: Mitnick, Carole D., et al.
Publicado: (2016)

Towards all-oral and shorter treatment regimens for drug-resistant tuberculosis
por: Weyer, Karin, et al.
Publicado: (2018)

Genotyping and molecular detection of multidrug-resistant Mycobacterium tuberculosis among tuberculosis lymphadenitis cases in Addis Ababa, Ethiopia
por: Zewdie, O., et al.
Publicado: (2017)

Mycobacterium tuberculosis Drug Resistance, Ghana
por: Owusu-Dabo, Ellis, et al.
Publicado: (2006)

Attitudes of Healthcare Workers about Prevention and Control of Nosocomial Multidrug-Resistant Tuberculosis Infection in Two Top-Ranked Tuberculosis Specialized Public Hospitals of Ethiopia
por: Kebede, Taye, et al.
Publicado: (2022)

Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia
por: Engström, Anna, et al.
Publicado: (2019)

Multidrug-resistant tuberculosis
por: Zager, Ellen M, et al.
Publicado: (2008)

Multidrug-resistant tuberculosis
por: Lemos, Antônio Carlos Moreira, et al.
Publicado: (2013)

Pharmacovigilance and tuberculosis: applying the lessons of thioacetazone
por: Falzon, Dennis, et al.
Publicado: (2014)

Assessing the impacts of short-course multidrug-resistant tuberculosis treatment in the Southeast Asia Region using a mathematical modeling approach
por: Han, Win Min, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on the global tuberculosis epidemic
por: Falzon, Dennis, et al.
Publicado: (2023)

The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership
por: Wang, Lixia, et al.
Publicado: (2017)

Multidrug-resistant Mycobacterium tuberculosis, Bangui, Central African Republic
por: Nouvel, Laurent X., et al.
Publicado: (2006)

The Role of Novel Approaches and New Findings in the Pharmacology of Tuberculosis Medicines in Improving Treatment Outcomes
por: Falzon, Dennis, et al.
Publicado: (2018)

Numbers needed to treat to prevent tuberculosis
por: Matteelli, Alberto, et al.
Publicado: (2015)

Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia
por: Carascal, Mark B., et al.
Publicado: (2022)

Pharmacotherapy for multidrug resistant tuberculosis
por: Chhabra, Naveen, et al.
Publicado: (2012)

The Threat of Multidrug-resistant Tuberculosis
por: Paul, Rudrajit
Publicado: (2018)

Fistulized multidrug-resistant tuberculosis
por: El Omri, Naoual, et al.
Publicado: (2017)

Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine
por: Chiang, Silvia Shinpei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_klqfld1kged7fg3rijr6dn7e0o